BIO, PhRMA press FDA for concrete details on new IT strategy

Af­ter the FDA un­veiled its over­ar­ch­ing IT strat­e­gy ear­li­er this fall, lob­by­ing groups like BIO and PhRMA, as well as tech gi­ant Google, are ask­ing the FDA for more de­tails on how it plans to ex­e­cute the strat­e­gy.

In a joint com­ment pub­lished Mon­day, PhRMA and BIO com­mend­ed the FDA for its stake­hold­er out­reach as it de­vel­oped the strat­e­gy, but they pressed the agency for more specifics on what it hopes to achieve with the strat­e­gy and how it plans to track the out­comes.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.